Detalhe da pesquisa
1.
Non-Necroptotic Roles of MLKL in Diet-Induced Obesity, Liver Pathology, and Insulin Sensitivity: Insights from a High-Fat, High-Fructose, High-Cholesterol Diet Mouse Model.
Int J Mol Sci
; 25(5)2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38474061
2.
Endoplasmic reticulum-mitochondria miscommunication is an early and causal trigger of hepatic insulin resistance and steatosis.
J Hepatol
; 77(3): 710-722, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358616
3.
ABO blood group does not influence Child-Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts.
Liver Int
; 42(6): 1386-1400, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35025128
4.
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.
BMC Infect Dis
; 22(1): 94, 2022 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35086481
5.
REDD1 deficiency protects against nonalcoholic hepatic steatosis induced by high-fat diet.
FASEB J
; 34(4): 5046-5060, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32043636
6.
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status.
J Hepatol
; 73(6): 1434-1445, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32615276
7.
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
Lancet
; 393(10179): 1453-1464, 2019 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30765123
8.
Validation of Baveno VI Criteria for Screening and Surveillance of Esophageal Varices in Patients With Compensated Cirrhosis and a Sustained Response to Antiviral Therapy.
Gastroenterology
; 156(4): 997-1009.e5, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768988
9.
Sofosbuvir-Daclatasvir is suboptimal in patients with genotype 2 chronic hepatitis C infection: real-life experience from the HEPATHER ANRS CO22 cohort.
J Viral Hepat
; 27(10): 964-973, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436335
10.
Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2).
Hepatology
; 70(4): 1336-1348, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30762895
11.
Phase 3, Multicenter Open-Label study to investigate the efficacy of elbasvir and grazoprevir fixed-dose combination for 8 weeks in treatment-naïve, HCV GT1b-infected patients, with non-severe fibrosis.
Liver Int
; 40(8): 1853-1859, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383275
12.
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus genotype 4 infection: A randomized study.
Liver Int
; 40(5): 1042-1051, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31765046
13.
Safety and Pharmacokinetics of Glecaprevir/Pibrentasvir in Adults With Chronic Genotype 1-6 Hepatitis C Virus Infections and Compensated Liver Disease.
Clin Infect Dis
; 69(10): 1657-1664, 2019 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-30923816
14.
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs.
Gastroenterology
; 155(5): 1436-1450.e6, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30031138
15.
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Gastroenterology
; 155(2): 431-442.e10, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29729258
16.
Non-virological factors are drivers of hepatocellular carcinoma in virosuppressed hepatitis B cirrhosis: Results of ANRS CO12 CirVir cohort.
J Viral Hepat
; 26(3): 384-396, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30380181
17.
Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice.
Hepatology
; 68(2): 515-532, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29457838
18.
12 Weeks of a Ribavirin-Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation.
Hepatology
; 68(4): 1277-1287, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29633389
19.
Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication.
Hepatology
; 68(4): 1245-1259, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29663511
20.
Safety and efficacy of the combination simeprevir-sofosbuvir in HCV genotype 1- and 4-mono-infected patients from the French ANRS CO22 hepather cohort.
BMC Infect Dis
; 19(1): 300, 2019 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30940090